Trial Profile
Pharmacokinetic interaction study with fixed high dose combinations of candesartan cilexetil and hydrochlorothiazide
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2012
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil/hydrochlorothiazide (Primary) ; Candesartan cilexetil; Hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 10 Jan 2012 New trial record